Mirtazapine Related Published Studies
Well-designed clinical trials related to Mirtazapine
Mirtazapine to reduce methamphetamine use: a randomized controlled trial. [2011.11]
Adjunct mirtazapine for negative symptoms of schizophrenia. [2011.10]
Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. [2011.07.30]
More evidence on proneurocognitive effects of add-on mirtazapine in schizophrenia. [2011.06.01]
Residual effects of esmirtazapine on actual driving performance: overall findings and an exploratory analysis into the role of CYP2D6 phenotype. [2011.05]
Add-on mirtazapine improves depressive symptoms in schizophrenia: a double-blind randomized placebo-controlled study with an open-label extension phase. [2011.04.06]
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. [2011.04]
Mirtazapine augmentation enhances cognitive and reduces negative symptoms in schizophrenia patients treated with risperidone: a randomized controlled trial. [2011.01.15]
Antidepressive effect of mirtazapine in post-myocardial infarction depression is associated with soluble TNF-R1 increase: data from the MIND-IT. [2011]
Adjunct mirtazapine for negative symptoms of schizophrenia. [2011]
Mirtazapine augmentation enhances cognitive and reduces negative symptoms in
schizophrenia patients treated with risperidone: a randomized controlled trial. [2011]
Efficacy of mirtazapine in preventing intrathecal morphine-induced nausea and vomiting after orthopaedic surgery*. [2010.12]
A single dose of mirtazapine modulates neural responses to emotional faces in healthy people. [2010.12]
Different effects of mirtazapine and venlafaxine on brain activation: an open randomized controlled fMRI study. [2010.09.21]
More evidence on additive antipsychotic effect of adjunctive mirtazapine in schizophrenia: an extension phase of a randomized controlled trial. [2010.08]
Venlafaxine and mirtazapine treatment lowers serum concentrations of dehydroepiandrosterone-sulfate in depressed patients remitting during the course of treatment. [2010.06]
Antidepressant treatment with mirtazapine, but not venlafaxine, lowers cortisol concentrations in saliva: a randomised open trial. [2010.05.15]
Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind, randomized, placebo-controlled study. [2010.05]
Longitudinal analysis of the suicidal behaviour risk in short-term placebo-controlled studies of mirtazapine in major depressive disorder. [2010.02]
The effect of mirtazapine add on therapy to risperidone in the treatment of schizophrenia: a double-blind randomized placebo-controlled trial. [2010.02]
More evidence on additive antipsychotic effect of adjunctive mirtazapine in
schizophrenia: an extension phase of a randomized controlled trial. [2010]
Mirtazapine in generalized social anxiety disorder: a randomized, double-blind,
placebo-controlled study. [2010]
Remission with mirtazapine and selective serotonin reuptake inhibitors: a
meta-analysis of individual patient data from 15 controlled trials of acute phase
treatment of major depression. [2010]
The effect of mirtazapine add on therapy to risperidone in the treatment of
schizophrenia: a double-blind randomized placebo-controlled trial. [2010]
Effects of add-on mirtazapine on neurocognition in schizophrenia: a double-blind,
randomized, placebo-controlled study. [2010]
Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation. [2009.07]
Influence of sex and CYP2D6 genotype on mirtazapine disposition, evaluated in Spanish healthy volunteers. [2009.06]
Early effects of mirtazapine on emotional processing. [2009.05]
Mirtazapine add-on therapy in the treatment of schizophrenia with atypical antipsychotics: a double-blind, randomised, placebo-controlled clinical trial. [2009.04]
Mirtazapine, a sedating antidepressant, and improved driving safety in patients with major depressive disorder: a prospective, randomized trial of 28 patients. [2009.03]
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: a double-blind, randomized, placebo-controlled trial. [2009.03]
Add-on mirtazapine enhances antipsychotic effect of first generation antipsychotics in schizophrenia: A double-blind, randomized, placebo-controlled trial. [2009.01.12]
The impact of reboxetine and mirtazapine on driving simulator performance and psychomotor function in depressed patients. [2008.12]
Neuroimaging of mirtazapine enantiomers in humans. [2008.10]
Mirtazapine versus other antidepressants in the acute-phase treatment of adults with major depression: systematic review and meta-analysis. [2008.09]
Two randomized placebo-controlled trials to evaluate the efficacy and tolerability of mirtazapine for the treatment of obstructive sleep apnea. [2008.06.01]
A placebo-controlled trial of mirtazapine for the management of methamphetamine withdrawal. [2008.05]
Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression. [2008.04]
Mirtazapine decreases the pain feeling in healthy participants. [2008.02]
Venlafaxine versus Mirtazapine in the Treatment of Undifferentiated Somatoform Disorder : A 12-Week Prospective, Open-Label, Randomized, Parallel-Group Trial. [2008]
Treatment of post-myocardial infarction depressive disorder: a randomized, placebo-controlled trial with mirtazapine. [2007.09]
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. [2007.04.05]
Combination of low-dose mirtazapine and ibuprofen for prophylaxis of chronic tension-type headache. [2007.02]
Efficacy of mirtazapine in obstructive sleep apnea syndrome. [2007.01.01]
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. [2007.01]
Effect of mirtazapine orally disintegrating tablets on health-related quality of life in elderly depressed patients with comorbid medical disorders: a pilot study. [2007]
The MAOA T941G polymorphism and short-term treatment response to mirtazapine and paroxetine in major depression. [2006.12.27]
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report. [2006.09]
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report. [2006.07]
Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients. [2006.07]
Low-dose mirtazapine: a new option in the treatment of antipsychotic-induced akathisia. A randomized, double-blind, placebo- and propranolol-controlled trial. [2006.06.01]
Cerebrovascular reactivity following administration of mirtazapine in healthy probands--a randomized, placebo controlled double-blind clinical study. [2006.06]
Mirtazapine Orally Disintegrating Tablets Versus Venlafaxine Extended Release: A Double-blind, Randomized Multicenter Trial Comparing the Onset of Antidepressant Response in Patients With Major Depressive Disorder. [2006.02]
Mirtazapine treatment of social phobia in women: a randomized, double-blind, placebo-controlled study. [2005.12]
Mirtazapine in amphetamine detoxification: a placebo-controlled pilot study. [2005.09]
Mirtazapine for obsessive-compulsive disorder: an open trial followed by double-blind discontinuation. [2005.04]
Actual driving performance and psychomotor function in healthy subjects after acute and subchronic treatment with escitalopram, mirtazapine, and placebo: a crossover trial. [2005.04]
Comparison of mirtazapine and fluoxetine in the treatment of major depressive disorder: a double-blind, randomized trial. [2005.04]
Mirtazapine and venlafaxine in the management of collateral psychopathology during alcohol detoxification. [2005.01]
Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients. [2005]
Well-designed clinical trials possibly related to Mirtazapine
Pharmacotherapy to control behavioral symptoms in children with autism. [2012]
Randomized comparison of selective serotonin reuptake inhibitor (escitalopram) monotherapy and antidepressant combination pharmacotherapy for major depressive disorder with melancholic features: a CO-MED report. [2011.10]
Combining medications to enhance depression outcomes (CO-MED): acute and long-term outcomes of a single-blind randomized study. [2011.07]
Serum lipoproteins improve after successful pharmacologic antidepressant treatment: a randomized open-label prospective trial. [2011.07]
Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol. [2011.05.11]
If at first you don't succeed: a review of the evidence for antidepressant augmentation, combination and switching strategies. [2011.01.01]
Efficacy of antidepressants for dysthymia: a meta-analysis of placebo-controlled
randomized trials. [2011]
Modafinil reduces microsleep during partial sleep deprivation in depressed patients. [2010.10]
Guideline recommendations for long-term treatment of depression with antidepressants in primary care--a critical review. [2010.06]
FKBP5 polymorphisms and antidepressant response in geriatric depression. [2010.03.05]
Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study. [2010.03]
Guideline recommendations for long-term treatment of depression with
antidepressants in primary care--a critical review. [2010]
Modafinil reduces microsleep during partial sleep deprivation in depressed
patients. [2010]
FKBP5 polymorphisms and antidepressant response in geriatric depression. [2010]
Assessment of the test-retest reliability of laboratory polysomnography. [2009.05]
Is the antidepressant venlafaxine effective for the treatment of functional dyspepsia? [2009.02]
Impact of the WHO depression guideline on patient care by psychiatrists: a randomized controlled trial. [2008.09]
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. [2008.03]
Association analysis between variants of the interleukin-1beta and the interleukin-1 receptor antagonist gene and antidepressant treatment response in major depression. [2008.02]
Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis. [2007.12]
The effect of short-term, low-dose tricyclic and tetracyclic antidepressant treatment on satiation, postnutrient load gastrointestinal symptoms and gastric emptying: a double-blind, randomized, placebo-controlled trial. [2007.11.20]
A monoamine oxidase B gene variant and short-term antidepressant treatment response. [2007.10.01]
Nonresponse to treatment for depression following myocardial infarction: association with subsequent cardiac events. [2007.09]
The role of sedation tests in identifying sedative drug effects in healthy volunteers and their power to dissociate sedative-related impairments from memory dysfunctions. [2007.08]
A monoamine oxidase B gene variant and short-term antidepressant treatment response. [2007.06.07]
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: Multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil. [2007.06]
Impact of a primary care intervention on smoking, drinking, diet, weight, sun exposure, and work risk in families with cancer experience. [2007.06]
Hematologic toxicity associated with interferon-based hepatitis C therapy in HIV type 1-coinfected subjects. [2007.05.15]
A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide-CRM(197) with a meningococcal group C conjugate vaccine in healthy infants: Challenge phase. [2007.05.10]
Randomized controlled trial to evaluate transdermal testosterone in female cancer survivors with decreased libido; North Central Cancer Treatment Group protocol N02C3. [2007.05.02]
Gastrojejunostomy versus stent placement in patients with malignant gastric outlet obstruction: a comparison in 95 patients. [2007.05.01]
Bioabsorbable anterior cervical plating: initial multicenter clinical and radiographic experience. [2007.05.01]
A comparison of two short education programs for improving low back pain-related disability in the elderly: a cluster randomized controlled trial. [2007.05.01]
Infliximab plus prednisone or placebo plus prednisone for the initial treatment of polymyalgia rheumatica: a randomized trial. [2007.05.01]
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trial. [2007.05.01]
A preliminary randomized, double-blind, placebo-controlled study of the safety and efficacy of ondansetron in the treatment of methamphetamine dependence. [2007.05.01]
The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study. [2007.05.01]
Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine. [2007.05.01]
Topical resiquimod 0.01% gel decreases herpes simplex virus type 2 genital shedding: a randomized, controlled trial. [2007.05.01]
Determinants of outcomes after head cooling for neonatal encephalopathy. [2007.05]
Effectiveness of trimethoprim/sulfamethoxazole for children with chronic active otitis media: a randomized, placebo-controlled trial. [2007.05]
|
